(Update2) Burford Capital acquires Gerchen Keller for $160M in cash, notes, stock and performance based shares

Burford Capital Ltd., the litigation finance firm run by CEO Christopher Bogart, agreed to acquire Gerchen Keller Capital LLC for $160 million in cash, Burford Capital stock and notes and $15 million in performance based shares. London-based Burford Capital is paying $93.75 million in cash on hand, $43.75 million in three-year notes, $22.5 million in [...]

By | December 14th, 2016|Financing, Patent Investing|0 Comments

Fortress reaches out for licensing help as it takes over IP from failed licensing companies and faces competition

Fortress Investment Group (FIG), whose IP secured lending business is run by Eran Zur, has been quietly reaching out to licensing executives to help it monetize patents it was forced to repossess from companies including Inventergy Global (INVT), Crossroads Systems (CRDS) and others, several people familiar with the matter said. The people familiar said Zur, [...]

By | December 13th, 2016|exec changes, Patent Investing, Patent Trolling|0 Comments

President-elect Trump’s remarks on one-China policy are creating uncertainty for patent intensive U.S. companies

The Chinese government is likely to respond deliberately and incrementally to President-elect Donald Trump’s unorthodox comments about the violability of the one-China policy with little impact on the intellectual property market, patent market observers say. The one-China policy has been a cornerstone of U.S.-China relations since the late 1970s when the U.S. agreed to open [...]

By | December 13th, 2016|China, Patent Investing|0 Comments

(Update1) Hayman Capital’s Bass sees Trump as ally in his campaign against invalid drug patents and high drug prices

J. Kyle Bass, the founder and chief investment officer of Hayman Capital Management, is hoping the Coalition for Affordable Drugs, the group he runs with IP Navigation Group founder Erich Spangenberg to challenge weak or invalid drug patents, has a new ally in President-elect Donald Trump. Trump, who complained on the campaign trail about runaway [...]

By | December 13th, 2016|drug patents, Patent Investing|0 Comments

WiLAN acquires patents from GlobalFoundries nearly a year after the two struck a licensing deal

WiLAN Inc. (WILN), the patent licensing company run by CEO Jim Skippen, said its Auriga Innovations Inc. unit has acquired a portfolio of patents covering semiconductor process technologies used in the manufacture of semiconductor devices from GlobalFoundries Inc. The Ottawa, Ontario-based company said the terms were confidential. Nearly a year ago, WiLAN’s Polaris Innovations subsidiary [...]

By | December 13th, 2016|Patent Investing|0 Comments

WiLAN says TV maker Tongfang Global agrees to renew multi-year licensing agreement

WiLAN Inc. (WILN) , the patent licensing company run by CEO Jim Skippen, said Tongfang Global Ltd., a Chinese television manufacturer, signed a multi-year license renewal agreement covering digital television technology for undisclosed terms. The Ottawa, Ontario-based company the license covers technologies for receiving and processing of broadcast television signals by televisions and the decoding and [...]

By | December 12th, 2016|China, licensing agreement, Patent Investing|0 Comments

Tech transfer may offer Trump way to make good on his pledge to combat IP theft, boost jobs

If President-elect Donald Trump wants to “make America great again” by combatting intellectual property theft, he could start by doing more to value the inventions and patents of the national laboratories, owned by various federal government agencies. The biggest patent filers in the U.S. Government are the Department of Defense, the Department of Energy, the [...]

By | December 10th, 2016|Patent Investing|0 Comments

Network-1 sets semi annual dividend at 5 cents payable in March and September

Network-1 Technologies Inc. (NTIP), the patent licensing company run by CEO Corey Horowitz, said its board approved the initiation of a dividend policy as part of Network-1's ongoing commitment to increasing shareholder value and return on investment. New York-based Network-1 said the newly-adopted dividend policy provides for the payment of a regular semi-annual dividend of [...]

By | December 9th, 2016|Patent Investing|0 Comments

(Update1) Court of Appeals for the Federal Circuit affirms PTAB invalidation of VirnetX patents

The Court of Appeals for the Federal Circuit on Friday Dec. 9 handed VirnetX Holding Corp. (VHC), the licensing company that has been unable to sustain hundred million dollar jury awards against Apple, a major loss affirming Patent Trial Appeal Board decisions invalidating the patents challenged in  six inter partes reviews and one inter partes [...]

By | December 9th, 2016|Federal Circuit, Patent Investing|0 Comments

Marathon Patent Group raises $5.2M in registered direct for patent acquisitions

Marathon Patent Group (MARA), the patent licensing company run by CEO Doug Croxall, said it raised $5.2 million in a register direct offering of common stock and concurrent private placement of stock priced at a 10.7% discount to be used for general corporate purposes including patent acquisitions. Los Angeles-based Marathon said it is issuing 3,481,997 [...]

By | December 9th, 2016|Financing, Patent Investing|0 Comments